CoChat

Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies

Open access
Li, Cheng-Ta, Yang, Kai-Chun, Lin, Wei-Chen · 2019 · Frontiers in Psychiatry
Cited by 162

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Glutamate is the major excitatory neurotransmitter in the human brain. Excessive glutamate release has been linked to stress and many neurodegenerative diseases. In addition, a growing body of evidence pinpoints that abnormalities of glutamatergic neurotransmission or glutamatergic dysfunction play an important role in the development of many major psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depressive disorder, and treatment-resistant depression). Recently, ketamine, an NMDA antagonist, has been demonstrated to have promisingly rapid antidepressant efficacy for treatment-resistant depression. Afterwards, many compounds that target at glutamate system are also available and possess potentials in the treatment of major psychiatric disorders. In this review, we will update evidence from recent human studies that directly or indirectly measure glutamatergic neurotransmission and function, including magnetic resonance spectroscopy (MRS), PET (positron emission tomography)/single-photon emission computed tomography (SPECT), and paired-pulse transcranial magnetic stimulation (ppTMS) on major psychiatric disorders. The newer generation of antidepressants targeting the glutamatergic system from human clinical studies is also reviewed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2018.00767

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

Metadata

Authors
Li, C.-T., Yang, K.-C., & Lin, W.-C.
Venue
Frontiers in Psychiatry
Published
2019-01-24
Volume
9
Pages
767-767
ISSN
1664-0640 (ISSN-L)
OpenAlex
W2914496888
Cited by
162
References
26
FWCI
11.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.